Search results
Results from the WOW.Com Content Network
Sun Pharmaceutical Industries Ltd. was established by Dilip Shanghvi in 1983 in Calcutta, West Bengal with five psychiatry products and a two-person marketing team. Today it is ranked number one in share of prescriptions with 12 classes of doctors in India and a market leader in Psychiatry, Neurology, Cardiology, Orthopaedics, Gastroenterology, Nephrology, Diabetology, Dermatology, Urology ...
Sun Pharma and Taro Announce Termination of Proposed Transaction HAWTHORNE, N.Y. & MUMBAI, India--(BUSINESS WIRE)-- Taro Pharmaceutical Industries Ltd. (NYS: TARO) ("Taro") and Sun Pharmaceutical ...
This is an accepted version of this page This is the latest accepted revision, reviewed on 15 November 2024. Indian Businessman Dilip Shanghvi Born (1955-10-01) 1 October 1955 (age 69) Amreli, Gujarat, India Alma mater Bhawanipur Education Society College, University of Calcutta Occupation(s) Founder and MD of Sun Pharmaceuticals Spouse Vibha Shanghvi Children 2 Dilip Shanghvi (born 1 October ...
(Reuters) -Mayne Pharma has filed a lawsuit against India's Sun Pharma over infringements of patents related to a certain product used for menopause-related vaginal pain, the Australian drugmaker ...
Taro Pharmaceutical Industries is an Israeli research-based pharmaceutical manufacturer that was publicly listed in the New York Stock Exchange before it was acquired by Sun Pharma. The company has more than 180 of its own drugs sold all over the world, reaching the markets of over 25 countries. [ 1 ]
In 2008, Japanese pharmaceutical company Daiichi Sankyo acquired a controlling share in Ranbaxy [2] and in 2014, Sun Pharma acquired 100% of Ranbaxy in an all-stock deal. The Sun Pharma acquisition brought all new management to Ranbaxy, which had been laden with controversy (see Controversies below). Sun is the world's fifth largest specialty ...
Get breaking Business News and the latest corporate happenings from AOL. From analysts' forecasts to crude oil updates to everything impacting the stock market, it can all be found here.
Other cases were now springing up in Texas and California. And state attorneys general were jumping into the act, apparently preparing their own qui tam cases. Through 2007 and 2008, each quarterly financial disclosure Johnson & Johnson filed with the SEC brought news of more subpoenas from state prosecutors.